Larotrectinib Capsules and Trastuzumab and Hyaluronidase
Determining the interaction of Larotrectinib Capsules and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Trastuzumab Injection (Intravenous)
- Larotrectinib Capsules-Trastuzumab Intravenous
- Larotrectinib Capsules-Trastuzumab-anns
- Larotrectinib Capsules-Trastuzumab-dkst
- Larotrectinib Capsules-Trastuzumab-dkst Intravenous
- Larotrectinib Capsules-Trasylol
- Trastuzumab and Hyaluronidase-Larotrectinib Oral Solution
- Trastuzumab and Hyaluronidase-Larotrectinib Sulfate
- Trastuzumab and Hyaluronidase-Lartruvo
- Trastuzumab and Hyaluronidase-Larynex
- Trastuzumab and Hyaluronidase-Laryng-O-Jet
- Trastuzumab and Hyaluronidase-Laryngesic